Heymann T D, Culling W
Department of Medicine, Kingston Hospital, Kingston upon Thames, Surrey, UK.
Postgrad Med J. 1994 Jun;70(824):455-6. doi: 10.1136/pgmj.70.824.455.
Thrombolysis has been very effective in reducing the morbidity and mortality from acute myocardial infarction. Serious adverse events are not uncommon, however. We describe a case in which a haemopericardium and tamponade developed in a patient with a history of recurrent idiopathic pericarditis and to whom streptokinase had been administered following a suspected myocardial infarction. The case highlights the need for caution in the administration of thrombolytics to patients with a documented history of pericarditis.
溶栓治疗在降低急性心肌梗死的发病率和死亡率方面一直非常有效。然而，严重不良事件并不罕见。我们描述了一例有复发性特发性心包炎病史的患者，在疑似心肌梗死后接受链激酶治疗后发生心包积血和心脏压塞的病例。该病例强调了对有明确心包炎病史的患者使用溶栓药物时需谨慎。
